KIC Ventures

What KIC Ventures does

KIC Ventures is a physician-led private equity healthtech investment firm founded in 2000 by Dr. Kingsley R. Chin, a practicing spine surgeon, that builds and operates a portfolio of majority-owned medical device companies focused on outpatient interventional spine surgery. The platform encompasses eight operating subsidiaries including AxioMed (viscoelastic lumbar disc replacement, FDA-submitted), NANISX (the InSpan interspinous fixation, Sacrix SI joint fusion, FacetFuse transfacet pedicle screw, and ELID endoscopic decompression platforms), NanoFuse Biologics (synthetic bioactive glass + DBM combination bone graft), LESS Spine, ELITE, MISquito, and Sagitechs—all unified under the proprietary LESS™ (Less Exposure Spine Surgery) treatment philosophy and REP™ (Restore function, Early diagnosis, Preserve anatomy) principles. The combined portfolio holds 35+ FDA-cleared devices and 100+ global patents, with 200,000+ devices implanted across 14 countries and 90+ peer-reviewed publications supporting clinical evidence.

The business model operates on three revenue streams: (1) hardware sales of medical devices and biologics through a direct U.S. field sales force covering states including Arkansas, Florida, Georgia, Illinois, Maryland, Mississippi, Oregon, Pennsylvania, and Washington, supplemented by an international distributor network; (2) private equity returns from portfolio company growth, strategic acquisitions, and potential exits (validated by a prior 100x return on the MANTIS percutaneous pedicle screw sale to Stryker); and (3) physician training services through the proprietary VET (Visit, Education, Training) Tour program at the Fort Lauderdale headquarters. KIC Ventures also operates a physician-investor model enabling 50+ physicians from 14 countries to invest retirement capital through Self-Directed IRAs, simultaneously serving as customers, distributors, and equity owners of the portfolio companies. Pricing is quote-based and aligned to ASC economics rather than hospital-based reimbursement.

The firm is headquartered in Fort Lauderdale, Florida with additional offices in Burlington, Massachusetts and Kingston, Jamaica. KIC has deployed over $70 million in cumulative capital ($40M+ founders, $30M+ investors) and is actively raising a $15 million Series A round (with $4M already committed by 27 investors) to support manufacturing scale-up, clinical studies, and global commercialization planned for 2026. The current leadership restructuring in 2026—with President/CFO Aditya Humad transitioning toward investment strategy and emerging technology initiatives—signals a strategic pivot toward AI integration, institutional partnerships, and expanded global investment activity.

Name

KIC Ventures

Legal name

KIC Ventures LLC

Website

https://kicventures.com

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

11–50 employees

Short description

KIC Ventures is a physician-led private equity healthtech investment firm that builds and operates a portfolio of spine surgery medical device companies—including AxioMed, NANISX, and NanoFuse Biologics—focused on outpatient interventional spine surgery under the proprietary LESS™ treatment philosophy. It serves spine surgeons, neurosurgeons, interventional pain physicians, and ASCs across 14 countries.

Ownership category

akta.pro rank

Product category

Spine Surgery Medical Devices and Biologics

NAICS

Biological Product (except Diagnostic) Manufacturing (325414), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Portfolio Management and Investment Advice (523940)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841), Pharmaceutical Preparations (2834)

akta.pro primary industry

Bone Graft Substitutes & Orthobiologics (Synthetic/Allograft/DBM) (HLAHAEAG)

akta.pro secondary industry

Cartilage, Bone & Musculoskeletal Regeneration (HLAAAGAH)

Keywords

• Spine surgery devices
• Interventional spine technology
• Outpatient spine surgery
• Medical device investment
• Minimally invasive implants

Headquarters

HQ city

Fort Lauderdale

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain, Others

Revenue model

1. Medical Device Portfolio Companies: Revenue from sale of spine surgery devices and biologics through portfolio companies including NANISX (InSpan, Sacrix, FacetFuse), AxioMed (viscoelastic disc replacement), and NanoFuse Biologics. Direct sales force and distributor network generate device sales to surgeons and ASCs.
2. Investment Management: Private equity returns through portfolio company growth, strategic acquisitions, and potential IPO exits. Raises capital from physicians, family offices, and institutional investors to fund portfolio company expansion.
3. Physician Training Services: VET (Visit, Education, Training) Tours provide hands-on surgical training programs for spine physicians at the Fort Lauderdale headquarters. Generates revenue through training fees and drives adoption of proprietary technologies.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels6 records

Core offering

KIC Ventures is a physician-led private equity healthtech investment firm that develops, manufactures, and sells a portfolio of proprietary medical devices and biologics for outpatient interventional spine surgery through its majority-owned portfolio companies (AxioMed, NANISX, NanoFuse Biologics, and others). Its offering includes interspinous fixation (InSpan), percutaneous SI joint fusion (Sacrix), transfacet pedicle screws (FacetFuse), viscoelastic lumbar disc replacement (AxioMed Freedom Disc), and synthetic bioactive bone regeneration biologics (NanoFuse), all guided by the LESS philosophy and REP treatment principles and complemented by physician training (VET Tours) and ASC partnership programs.

Product overview

KIC Ventures is a physician-led private equity healthtech investment firm operating as a platform of multiple portfolio companies focused on outpatient interventional spine surgery. The company offers a diversified portfolio of medical devices organized under two main sub-brands: NANISX (delivering differentiated interventional spine innovations including InSpan interspinous fixation, Sacrix SI joint fusion, FacetFuse transfacet pedicle screws, and ELID endoscopic decompression) and AxioMed (offering the FDA-submitted viscoelastic disc replacement platform including the Freedom Lumbar Disc for motion-preserving spine surgery). Supporting these device platforms are NanoFuse Biologics (the world's only FDA-cleared synthetic bioactive glass and DBM combination for bone regeneration), regenerative biologics, and physician education services through VET Tours. The entire portfolio is guided by the proprietary LESS (Less Exposure Spine Surgery) philosophy and REP treatment principles (Restore function, Early diagnosis, Preserve anatomy).

Differentiator

Problem solved

Functional benefit

Brands

• NANISX: Interventional spine innovations platform delivering differentiated technologies like InSpan, Sacrix, and FacetFuse for LESS invasive stabilization and decompression in ASCs.
• AxioMed
• NanoFuse Biologics
• LESS Spine
• LES Clinic
• Southern Health Lawyers LLC

Products and services

• InSpan Interspinous Fixation Patented interspinous fixation technology for minimally invasive stabilization of the spine, used by spine surgeons performing outpatient procedures in ASCs.
• Sacrix SI Joint Fusion Invented 100% fluoroscopic percutaneous lateral-oblique sacroiliac joint fusion technique with patented titanium implants, used by spine surgeons and interventional pain physicians for outpatient SI joint treatment.
• FacetFuse Transfacet Pedicle Screw Transfacet pedicle screw fixation technology for percutaneous spine fusion in the outpatient setting, used by spine surgeons for minimally invasive stabilization procedures.
• NanoFuse Biologics FDA-cleared synthetic bioactive glass and demineralized bone matrix (DBM) combination biologics technology for bone regeneration in spinal fusion procedures, used by spine surgeons and ASCs.
• AxioMed Freedom Viscoelastic Lumbar Disc Viscoelastic total disc replacement platform designed to restore natural spinal motion and reduce the need for spinal fusion. Generates 70% less wear and biologically safer particles than ball-and-socket designs, with zero mechanical failures across 30 million test cycles. Targeted at spine surgeons and patients seeking motion-preserving alternatives to fusion.
• ELID Endoscopic Lumbar Interbody Decompression Endoscopic lumbar decompression system designed for precise, minimally invasive treatment of lumbar spinal conditions, used by spine surgeons performing outpatient endoscopic procedures.
• VET Tours (Visit, Education, Training) Hands-on surgical training program for spine physicians at the Fort Lauderdale headquarters, providing structured coaching and procedural skills development to enable adoption of LESS Exposure Spine Surgery techniques and REP principles. Used by spine surgeons, neurosurgeons, and interventional pain physicians.
• ASC Partnership Program Comprehensive partnership program for Ambulatory Surgery Centers including surgeon training and certification, premium case coverage and in-OR support, payer authorization and reimbursement assistance, and clinical research participation. Targeted at ASCs seeking to establish or expand outpatient spine service lines.

Quantifiable outcome

• 70% less wear and biologically safer particles compared to traditional ball-and-socket disc designs
• +4 more outcomes

Named customers3 records

Segments5 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Four partnerships are on record, tiered supporting, core and minor.

• Southern Health Lawyers LLCsupportingImplementation/ SI/ Consulting Partner · 1 July 2024Healthcare-focused law firm (A Sanders and Mustari Lawfirm) providing legal support to ensure KIC Ventures meets all regulatory requirements. Jeffrey Mustari, Esq leads partnership from Atlanta office. Since July 2024, the firm has been providing legal counsel on healthcare regulations, compliance, and corporate integrity matters.
• AxioMedcoreStrategic or Co-development PartnerAxioMed is a KIC Ventures portfolio company focused on viscoelastic disc replacement technology. KIC Ventures created AxioMed and partnered with AxioMed for the Freedom Lumbar Disc technology designed to restore natural spinal motion. Study published in JBJS demonstrates AxioMed's viscoelastic disc generates 70% less wear than ball-and-socket designs with zero mechanical failures across 30 million cycles.
• ForbesBLKminorGTM or Marketing PartnerDr. Kingsley R. Chin attended ForbesBLK Summit 2025 as VIP guest, aligning KIC Ventures' Spine HealthTech vision with Vista Equity's value-building model. Summit featured keynotes from Robert F. Smith and Stephen A. Smith emphasizing leadership and innovation.
• LESS SocietycoreStrategic or Co-development PartnerProfessional society advancing Technology, Investments, Education, and Research (TIER) in Interventional Spine Surgery (ISSU). KIC Ventures co-founded and supports the society as the primary platform for physician community building, training certification, and research collaboration.

Scale indicators12 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Globus Medical: Major spine device company offering a broad portfolio of MIS, motion-preserving, and biologics products for ASC and hospital settings. Direct competitor to KIC's NANISX and AxioMed platforms across the same surgeon customer base.
• NuVasive: Pure-play spine company with deep MIS and motion-preserving technology portfolio, including disc replacement and lateral approaches. Competes head-to-head with KIC's outpatient interventional spine and disc replacement strategy.
• SI-BONE: Specialist in minimally invasive SI joint fusion with iFuse implant system. Directly comparable to KIC's Sacrix portfolio company in the same SI joint fusion category and ASC channel.
• Alphatec Spine: Spine-focused company developing lateral, MIS, and biologics technologies for ASC adoption. Comparable to KIC's outpatient interventional spine strategy with overlapping surgeon customers.
• Spineology: Spine specialist focused on minimally invasive fusion and anatomic motion-preserving devices. Comparable portfolio scope and ASC distribution focus to KIC's NANISX and AxioMed platforms.

Broad incumbents

• Stryker: Diversified medical device incumbent and acquirer of KIC's MANTIS pedicle screw system. A large-scale buyer and competitor across spine, neuro, and biologics, representing both an exit channel and a competitive threat.
• Medtronic: Largest spine and neurosurgery incumbent with broad implant, navigation, and biologics portfolios. Sets pricing, reimbursement, and surgeon training standards that KIC must navigate to scale outpatient spine products.

Emerging players

• Carlsmed: Emerging player in personalized spine surgery with aprevo cervical and lumbar devices. Comparable as a smaller, innovation-driven spine company pursuing ASC and motion-preserving opportunities adjacent to KIC.
• Viseon: Emerging spine company developing single-use visualization and MIS enabling technologies. Adjacent to KIC's MISquito and LESS philosophy of minimally invasive outpatient spine surgery.
• Treace Medical Concepts: Musculoskeletal specialist focused on minimally invasive foot and ankle procedures, including the Lapiplasty system. Comparable as a smaller physician-driven MedTech company with a strong ASC and surgeon-training go-to-market model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xx.com/kicventures
• YouTubeyoutube.com/@kicventuresgroup8711
• Facebookfacebook.com/p/KICVentures-100054281030301
• LinkedInlinkedin.com/company/kicventures

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries8 records

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about KIC Ventures